Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro and in vivo. Silencing Socs1 in the LLC line confers increased response to.

Slides:

Advertisements

Similar presentations

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.

Advertisements

Fig. 6. Knockdown of TCF-4 inhibits TCTP-induced glioma cell proliferation in vitro and in vivo. (A) TCF-4 was knocked down in U-251/TCTP and H-4/TCTP.

Molecular Therapy - Nucleic Acids

Volume 15, Issue 6, Pages (June 2009)

Volume 20, Issue 4, Pages e4 (April 2017)

Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo Jessica A. Yu, MD, David Mauchley, MD, Howard Li, MD, Xianzhong.

KIND1 Loss Sensitizes Keratinocytes to UV-Induced Inflammatory Response and DNA Damage Xiaoling Zhang, Suju Luo, Joseph Wu, Long Zhang, Wen-hui Wang,

Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin

Myocardin-Related Transcription Factors A and B Are Key Regulators of TGF-β1- Induced Fibroblast to Myofibroblast Differentiation Beverly J. Crider, George.

Dual Role of Apoptosis-Associated Speck-Like Protein Containing a CARD (ASC) in Tumorigenesis of Human Melanoma Weimin Liu, Yuchun Luo, Jeffrey H. Dunn,

Volume 21, Issue 9, Pages (November 2017)

Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.

MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma

NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.

Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer

Volume 28, Issue 4, Pages (October 2015)

Expression of FUT9 supports tumor development

Volume 23, Issue 6, Pages (June 2013)

Volume 21, Issue 6, Pages (June 2013)

H31m1-PDL1 cells form progressively growing tumors in WT mice.

PDGFRα GBM primary cultures demonstrate titratable and temporal DOX-inducible expression of hPDGF-A and receptor activation. PDGFRα GBM primary cultures.

DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA Jason W. Upton, William J.

Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity Tina.

Molecular Therapy - Nucleic Acids

Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1

Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.

Microarray analysis of phospho-Twist1–responsive genes.

Regulation of Fibulin-2 Gene Expression by Integrin α3β1 Contributes to the Invasive Phenotype of Transformed Keratinocytes Dara S. Missan, Sridar V.

Volume 16, Issue 11, Pages (September 2016)

Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones

Molecular Therapy - Nucleic Acids

Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang Molecular Therapy

Volume 20, Issue 6, Pages (August 2017)

GRM7 Regulates Embryonic Neurogenesis via CREB and YAP

Volume 8, Issue 3, Pages (August 2014)

Change in mRNA expression of Glasso network genes in differentiated PC12 cells following Caprin2 knockdown or Caprin2 overexpression. Change in mRNA expression.

Volume 36, Issue 2, Pages (October 2009)

MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma

Volume 15, Issue 6, Pages (June 2009)

Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8+ Immunity In Vivo Tzu-Yang Weng, Chia-Jung Li, Chung-Yen.

P300 depletion is lethal in cancer cells harboring loss-of-function mutations in CBP. A, synthetic-lethal effects assessed by colony formation assay. p300.

Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts Therapeutic activity of gal‐encapsulated cytotoxic drugs on tumor xenografts.

Knockdown efficiency of different shRNAs.

Volume 20, Issue 3, Pages (March 2012)

TGFBRAP1 plays a critical role in CHIT1 augmentation of TGF-β1 signaling and TGFβR expression. TGFBRAP1 plays a critical role in CHIT1 augmentation of.

Silencing Ifngr1 in the CMT167 line confers decreased response to IFNγ in vitro and in vivo. Silencing Ifngr1 in the CMT167 line confers decreased response.

eIF5A-PEAK1 signaling regulates KRAS protein expression.

Socs1 KD tumors show alterations in multiple populations.

PhenoGraph-based visualization on tSNE plots.

TGF-β stimulates SMAD7 expression via FOXO3.

LLC cells exhibit a blunted response to IFNγ in vitro and in vivo compared with CMT167. LLC cells exhibit a blunted response to IFNγ in vitro and in vivo.

The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2 Cheng-Cao Sun, Ling Zhang, Guang.

Socs1 KD tumors exhibit a more T-cell–inflamed phenotype and increased T-cell activation. Socs1 KD tumors exhibit a more T-cell–inflamed phenotype and.

CHIT1 enhances and plays a critical role in TGF-β1–stimulated signaling and fibrotic responses in vivo. CHIT1 enhances and plays a critical role in TGF-β1–stimulated.

Socs1 KD tumors exhibit a more T cell–inflamed phenotype and increased CD8+ T cell activation. Socs1 KD tumors exhibit a more T cell–inflamed phenotype.

Nrf2−/− mice had higher TGF-β1 transcription and FN expression.

Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro. Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro.

Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer

NOX1-deficient mice do not respond to GKT771 and exhibit reduced B16-F10 tumor growth associated with decreased production of angiogenic factors and minor.

Analysis of tumor-infiltrating CD8+ T cells and effect of T and NK cell depletion. Analysis of tumor-infiltrating CD8+ T cells and effect of T and NK cell.

H19 was essential for cancer metastasis.

EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo. EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo.

The antitumor and antimetastatic properties of PF in the MX1 orthotopic model. The antitumor and antimetastatic properties of PF in the.

PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination. PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination.

Neurotensin and insulin induce increases in CTGF, CYR61, and CXCL5 gene expression and stimulate cell proliferation and colony via YAP/TAZ in PDAC cells.

NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.

Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.

MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.

PD-L1 expression is not associated with PTEN expression status in melanomas. PD-L1 expression is not associated with PTEN expression status in melanomas.

Presentation transcript:

Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro and in vivo. Silencing Socs1 in the LLC line confers increased response to IFNγ in vitro and in vivo. (A) In vitro mRNA expression of Socs1 in FPKM as assessed by RNA-Seq in LLC and CMT167 cells. (B) Immunoblots of LLC or CMT167 cells treated with ±10 ng/ml IFNγ in vitro for a time course ranging from 15 min to 24 h, showing SOCS1 expression relative to the housekeeping gene β-ACTIN. Two separate shRNAs targeting Socs1 (LLC-sh20 and LLC-sh21) and a nontargeting control vector (LLC-NT) were transduced into LLC cells expressing luciferase. LLC cells were then screened for functional and stable knockdown of Socs1 after 10 d of puromycin selection. (C) Immunoblots showing p-STAT1, total STAT1, and β-ACTIN levels of the LLC-NT, LLC-sh20, and LLC-sh21 cell lines ± IFNγ at 15 min or 1 h in vitro.(D) mRNA expression of Socs1 via qRT-PCR shown as absolute values (SQ values) normalized to the housekeeping gene Actb. Statistics compare the LLC-NT line to the knockdown cell lines. (E) Immunoblot for SOCS1 relative to β-ACTIN protein levels in the LLC-NT, LLC-sh20, and LLC-sh21 cell lines in vitro at baseline. LLC-NT or LLC-sh21 cells were orthotopically injected into the lungs of syngeneic mice, established for 7 d, then were treated with either an isotype control antibody (IgG2a) or an anti–PD-1 antibody for 2 wk followed by terminal euthanization at 3 wk post tumor cell injection. (F) Primary tumor volume of lung tumors was assessed using digital calipers. LLC-sh21 cells were injected into the flanks of syngeneic mice, established for 7 d, then were treated as in (F). (G) Primary tumor volume of subcutaneous tumors (Flank) was also assessed with digital calipers. Error bars represent the mean of the data ± SEM after a t test (A, G) or a one-way ANOVA (D, F) (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). Source data are available for this figure. Bonnie L Bullock et al. LSA 2019;2:e201900328 © 2019 Bullock et al.